- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Toradol
Synonyms :
ketorolac
Class :
NSAIDs
Dosage Forms & Strengths
Tablet
10 mg
Prefilled syringe
15mg/ml
30mg/ml
60mg/2ml
Injectable solution
15mg/ml
30mg/ml
Administer dose of 30 mg intravenously every 6 hours and maximum limit of up to 120 mg daily
Administer dose of 30 mg intramuscularly every 6 hours and maximum limit of up to 120 mg daily
Take 20 mg orally one time after intravenous or intramuscular therapy
After this take 10 mg every 4 to 6 hours and maximum limit of up to 40 mg daily
Dosing Considerations
Total duration of therapy should not be more than five days
Reduce daily dose in patients specially those who are more than 65 years old and less than 50 kg weight
Dosing Modifications
Renal impairment
Severe: Avoid usage
Moderate: Use 50% of suggested dose and not more than 60 mg daily via intramuscular or intravenous route
Hepatic impairment
Study not performed
Dosage Forms & Strengths
Tablet
10 mg
Prefilled syringe
15mg/ml
30mg/ml
60mg/2ml
Injectable solution
15mg/ml
30mg/ml
Safety and efficacy not determined in less than two years old
2-16 years:
Single dose: administer 0.5 mg/kg through intravenous or intramuscular one time and not more than 15 mg dose
Multiple dose: administer 0.5 mg/kg through intravenous or intramuscular every 6 hours and for not more than 5 days
>16 years and less than 50 kg:
Administer dose of 15 mg intravenously every 6 hours and maximum limit up to 60 mg daily
Administer dose of 15 mg intramuscularly every 6 hours and maximum limit up to 60 mg daily
Take 10 mg orally one time after intravenous or intramuscular therapy
After this take 10 mg every 4 to 6 hours and maximum limit up to 40 mg daily
>16 years and more than 50 kg:
Administer dose of 30 mg intravenously every 6 hours and maximum limit up to 120 mg daily
Administer dose of 30 mg intramuscularly every 6 hours and maximum limit up to 120 mg daily
Take 20 mg orally one time after intravenous or intramuscular therapy
After this take 10 mg every 4 to 6 hours and maximum limit up to 40 mg daily
Dosing Considerations
Avoid using in pediatric patients
Total duration of therapy should not more than five days
Refer to adult dosing
Ketorolac may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
Ketorolac may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
Ketorolac may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
Ketorolac may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
Ketorolac may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may have an increasingly adverse effect when combined with aspirin.
ketorolac: they may increase the toxic effect of pentoxifylline
May enhances the effects of the other by pharmacodynamic synergism
may increase the toxic effect
probenecid: they may enhance the serum concentration of ketorolac
it increases the toxicity of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
Combining ketorolac with pranlukast may cause a reduction in the ketorolac’s metabolism
may enhance the risk or severity of hypertension when combined
Actions and Spectrum
Prostaglandins, which have a role in inflammation and pain, are produced when ketorolac is used. It relieves pain by preventing the activity of the cyclooxygenase (COX) enzymes, notably COX-1 and COX-2, which reduce the formation of prostaglandins.
ketorolac is frequently used to treat moderate to severe post-operative pain, including that associated with orthopaedic, dental, and gynaecological procedures.
Frequency defined
<1%
Anaphylaxis
Cholestatic jaundice
Depression
Urinary frequency
Stomatitis
Urinary retention
Euphoria
Pallor
Rectal bleeding
Melena
Vasodilation
Nervousness
Peptic ulcer
Rash
Insomnia
Laryngeal/lingual edema
Increased liver function test values
Hypotension
Dysgeusia
Difficulty in concentration
Blurred vision
Liver failure
Oliguria
Hemolytic-uremic syndrome
Abnormal thinking
Hyponatremia
Bronchospasm
Hepatitis
Hyperkalemia
1-10%
Diarrhea (3-9%)
Pruritus (3-9%)
Edema (1-3%)
Hypertension (4%)
Constipation (<3%)
Purpura (<3%)
Drowsiness (6%)
Increased serum creatinine (2%)
Dizziness (3-9%)
Increased blood urea nitrogen (BUN) (3%)
>10%
Dyspepsia (12-13%)
Nausea (12-13%)
Somnolence (3-14%)
GI pain (12-13%)
Headache (17%)
Black Box Warning
The risk of major cardiovascular thrombotic events, such as heart attack and stroke, may rise after taking ketorolac. ketorolac use is associated with an increased risk of gastrointestinal bleeding, ulceration, and perforation, which can be fatal.
Contraindication/Caution:
Contraindication:
Caution:
Pregnancy warnings:
Pregnancy category: C and D (in third trimester)
Lactation: Excretion into human milk known with multiple doses and avoid its use.
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
A non-steroidal anti-inflammatory medication (NSAID) with analgesic, anti-inflammatory, and antipyretic effects is ketorolac. By preventing the production of prostaglandins, which are chemical mediators involved in pain, inflammation, and fever, it has an anti-inflammatory effect. ketorolac’s analgesic and anti-inflammatory actions are brought about through COX-1 inhibition.
Pharmacodynamics
ketorolac inhibits COX-2, which reduces the generation of prostaglandins that promote inflammation.The ability of ketorolac to prevent prostaglandin formation also applies to controlling body temperature. The production of COX-2-mediated prostaglandins is a key factor in the development of fever. ketorolac can aid in bringing down a fever-related rise in body temperature by lowering prostaglandin levels.
Pharmacokinetics
Absorption
ketorolac is well absorbed following oral administration.
Intravenous administration of ketorolac provides immediate and complete bioavailability.
Distribution
ketorolac distributes widely throughout the body and has a moderate volume of distribution.
Metabolism
The significant hepatic metabolism of ketorolac occurs mainly by glucuronidation and, to a lesser extent, hydroxylation.
Elimination and excretion
The kidneys are primarily responsible for eliminating ketorolac and its metabolites. Less than 1% of the dosage is eliminated unaltered, leaving about 92% of it in the urine.
Administration
The oral tablets are swallowed whole with a glass of water.
Intramuscular injections of ketorolac are typically administered in the upper outer quadrant of the gluteal region.
Intravenous ketorolac is administered as a slow injection, usually over a period of 15 seconds to 1 minute.
Patient information leaflet
Generic Name: ketorolac
Why do we use ketorolac?
Following surgical treatments, ketorolac is frequently used to relieve discomfort. During the healing process, it can help with pain relief, inflammatory reduction, and general comfort.
ketorolac is useful for treating the acute pain brought on by musculoskeletal problems such sprains, strains, and sports injuries. It can offer comfort by easing discomfort and inflammation in afflicted tissues.
ketorolac can be used to treat the severe discomfort linked to renal colic, which is brought on by kidney stones passing through the kidneys.